CIK 0000879407
- Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460408024
- Phone
- +1 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-15 | Anzalone Christopher Richard Chief Executive Officer | Sale | −21,321 | $69.28 | $1.5M | 3,979,402 |
| 2025-12-15 | Anzalone Christopher Richard Chief Executive Officer | Sale | −8,147 | $69.96 | $570K | 3,971,255 |
| 2025-12-05 | PERRY MICHAEL S Director | Sale | −16,250 | $61.03 | $992K | 115,240 |
| 2025-11-28 | Ferrari Mauro Director | Sale | −8,750 | $56.39 | $493K | 68,764 |
| 2025-10-01 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −20,000 | $35.00 | $700K | 212,122 |
| 2025-09-12 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −15,000 | $30.00 | $450K | 232,122 |
| 2025-09-02 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −15,000 | $25.00 | $375K | 247,122 |
| 2025-08-15 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −9,389 | $20.00 | $188K | 262,122 |
| 2025-08-13 | Hamilton James C Chief Medical Officer | Sale 10b5-1 | −611 | $20.00 | $12K | 271,511 |
| 2025-04-11 | Anzalone Christopher Richard Chief Executive Officer | Sale | −50,800 | $11.49 | $584K | 3,921,255 |
| 2025-04-10 | Anzalone Christopher Richard Chief Executive Officer | Sale | −50,000 | $10.87 | $544K | 3,972,055 |
| 2025-04-09 | Anzalone Christopher Richard Chief Executive Officer | Sale | −35,305 | $9.93 | $351K | 4,027,072 |
| 2025-04-09 | Anzalone Christopher Richard Chief Executive Officer | Sale | −3,400 | $10.75 | $37K | 4,023,672 |
| 2025-04-09 | Anzalone Christopher Richard Chief Executive Officer | Sale | −1,617 | $11.76 | $19K | 4,022,055 |
| 2025-03-13 | Anzalone Christopher Richard Chief Executive Officer | Sale | −51,425 | $15.07 | $775K | 4,062,377 |
| 2025-03-04 | Anzalone Christopher Richard Chief Executive Officer | Sale 10b5-1 | −133,333 | $17.02 | $2.3M | 3,773,802 |
| 2025-03-03 | Anzalone Christopher Richard Chief Executive Officer | Sale 10b5-1 | −166,667 | $18.03 | $3.0M | 3,907,135 |
| 2025-01-23 | OLUKOTUN ADEOYE Y Director | Sale 10b5-1 | −959 | $21.00 | $20K | 35,781 |
| 2025-01-07 | O'Brien Patrick COO and General Counsel | Sale 10b5-1 | −8,000 | $19.69 | $158K | 527,201 |
| 2025-01-07 | Myszkowski Kenneth Allen Chief Financial Officer | Sale 10b5-1 | −8,000 | $19.70 | $158K | 465,433 |
Page 4 of 23 · 444 trades